We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSant Uk.10te% Regulatory News (SAN)

Share Price Information for Sant Uk.10te% (SAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 147.75
Bid: 145.50
Ask: 150.00
Change: 0.00 (0.00%)
Spread: 4.50 (3.093%)
Open: 147.75
High: 147.75
Low: 147.75
Prev. Close: 147.75
SAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Santander UK Pass 2019 Bank of England Stress Test

16 Dec 2019 18:02

RNS Number : 0596X
Santander UK Group Holdings PLC
16 December 2019
 

 

16 December 2019

 

SANTANDER UK GROUP HOLDINGS PLC

 

SANTANDER UK PASSES THE 2019 BANK OF ENGLAND STRESS TEST

 

Santander UK notes the publication of the results of the 2019 stress tests conducted on seven major UK banks and building societies by the Bank of England. Santander UK has passed the stress test and, as a result of the exercise, the Bank of England does not require Santander UK to undertake any actions.

 

Since the introduction of IFRS 9 in January 2019, the stress test results are published on an IFRS 9 transitional and non-transitional basis, over a five-year stress period to the end of 2023.

 

Santander UK reported a CET 1 capital ratio of 13.9% as at 30 September 2019.

 

On an IFRS 9 transitional basis, Santander UK's lowest post-stress CRD IV end-point common equity tier 1 ('CET 1') capital ratio was modelled to be 9.5% before management actions and 10.8% after allowed management actions. On an IFRS 9 non-transitional basis, Santander UK's lowest post-stress CRD IV end-point CET 1 capital ratio was modelled to be 9.9% before management actions and 10.4% after allowed management actions.

 

These results are in excess of the CET 1 hurdle rate established by the Bank of England of 8.1% on an IFRS 9 transitional basis, and 7.3% on an IFRS 9 non-transitional basis.

 

The Bank of England's CET1 hurdle rate comprises the CRR Pillar 1 minimum of 4.5% together with a Pillar 2A CET1 requirement, an estimate of the applicable Systemic Risk Buffer and an adjustment to offset the pro-cyclical impacts of IFRS 9. Santander UK expects that a Pillar 2A requirement of 2.7% will be set in the first quarter of 2020.

 

On an IFRS 9 transitional basis Santander UK's lowest post-stress end-point leverage ratio, over a five-year stress period to the end of 2023, was modelled to be 3.2% before management actions and 3.8% after allowed management actions. On an IFRS 9 non-transitional basis Santander UK's lowest post-stress end-point leverage ratio, over a five-year stress period to the end of 2023, was modelled to be 3.3% before management actions and 3.7% after allowed management actions.

 

After allowed management actions, these results are in excess of the leverage threshold established by the Bank of England of 3.57% on an IFRS 9 transitional and 3.25% on an IFRS 9 non-transitional basis. Santander UK reported a leverage ratio of 4.6% as at 30 September 2019, up from 4.5% as at 31 December 2018. As at 30 September 2019 the leverage exposure was £274bn.  

 

 

 

 

Contacts

Bojana Flint

Director of Investor Relations & Strategic Initiatives

020 7756 6474

Adam Williams

Head of Media Relations

020 7756 5533

Disclaimer

Santander UK Group Holdings plc (Santander UK), Santander UK plc and Banco Santander caution that this announcement may contain forward-looking statements. Such forward-looking statements are found in various places throughout this announcement. Words such as "believes", "anticipates", "expects", "intends", "aims" and "plans" and other similar expressions are intended to identify forward-looking statements, but they are not the exclusive means of identifying such statements. Forward-looking statements include, without limitation, statements concerning our future business development and economic performance. These forward-looking statements are based on management's current expectations, estimates and projections and both Santander UK and Banco Santander caution that these statements are not guarantees of future performance. We also caution readers that a number of important factors could cause actual results to differ materially from the plans, objectives, expectations, estimates and intentions expressed in such forward-looking statements. We have identified certain of these factors in the forward looking statements on page 243 of the Santander UK Group Holdings plc 2018 Annual Report. Investors and others should carefully consider the foregoing factors and other uncertainties and events. Undue reliance should not be placed on forward-looking statements when making decisions with respect to Santander UK, Santander UK plc, Banco Santander and/or their securities. Such forward-looking statements speak only as of the date on which they are made, and we do not undertake any obligation to update or revise any of them, whether as a result of new information, future events or otherwise. Statements as to historical performance, historical share price or financial accretion are not intended to mean that future performance, future share price or future earnings for any period will necessarily match or exceed those of any prior quarter.

Santander UK is a frequent issuer in the debt capital markets and regularly meets with investors via formal roadshows and other ad hoc meetings. In line with Santander UK's usual practice, over the coming quarter it expects to meet with investors globally to discuss this Quarterly Management Statement, the results contained herein and other matters relating to Santander UK.

 

Nothing in this announcement constitutes or should be construed as constituting a profit forecast.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCTFBPTMBMBBML
Date   Source Headline
25th Feb 20096:00 pmRNSDirectorate Change
5th Feb 20097:30 amRNSStatement for Preference Shareholders
5th Feb 20097:30 amRNSTrading Statement
20th Jan 200910:24 amRNSSupplementary Prospectus
16th Jan 20097:30 amRNSManagement Change
16th Jan 20097:30 amRNSManagement Changes
9th Jan 200911:00 amRNSChange to Company Structure
9th Jan 200911:00 amRNSChange to Company Structure
9th Jan 200910:59 amRNSChange to Company Structure
18th Dec 20083:45 pmRNSSupplementary Prospectus
17th Dec 200811:32 amRNSChange to Company Structure
17th Dec 200811:04 amRNSChange to Company Structure
17th Dec 200811:00 amRNSChange to Company Structure
3rd Dec 200810:01 amRNSSupplementary Prospectus
25th Nov 200812:27 pmRNSNOTICE OF FINAL AGGREGATE NOMINAL AMOUNT
5th Nov 200811:19 amRNSSupplementary Prospectus - EMTN Programme
28th Oct 20087:30 amRNSTrading Statement
21st Oct 20082:00 pmRNSAbbey and A&L Management Changes
21st Oct 20082:00 pmRNSAbbey and A&L Management Changes
13th Oct 20087:50 amRNSCapital injection
13th Oct 20087:50 amRNSCapital Injection
13th Oct 20087:30 amRNSDirectorate Change
13th Oct 20087:30 amRNSDirectorate Change
8th Oct 20081:12 pmRNSAbbey welcomes HM Treasury's announcement
29th Sep 20088:45 amRNSAcquisition
29th Sep 20087:44 amRNSB&B's Direct Channels & Deposits Transfer to Abbey
17th Sep 200811:27 amRNSSupplemental Prospectus
17th Sep 200811:12 amRNSSupplemental Prospectus
29th Aug 20084:20 pmRNSInterim Results
29th Jul 20087:30 amRNSFor the six months to 30 June
18th Jul 20085:18 pmRNSSupplementary Prospectus
23rd Jun 200811:18 amRNSResult of AGM
22nd May 20082:27 pmRNSNotice of AGM
13th May 20088:16 amRNSRedemption Notice
29th Apr 20087:30 amRNSQ1 Trading Statement
28th Mar 20082:19 pmRNSAnnual Information Update
27th Mar 200812:30 pmRNSPublication of Prospectus
12th Mar 20086:49 pmRNSPublication of Prospectus
5th Mar 200810:32 amRNSAnnual Report and Accounts
7th Feb 20087:30 amRNSTrading Statement
28th Dec 200712:00 pmRNSDirectorate Change
25th Oct 20077:30 amRNS3rd Quarter Results
11th Sep 20077:30 amRNSInterim Results
17th Aug 20079:45 amRNSAIM Rule 26 compliance
1st Aug 200710:24 amRNSRedemption Notice
26th Jul 20077:30 amRNSInterim Results
19th Jul 20073:41 pmRNSResult of AGM
17th Jul 20071:30 pmRNSManagement Change
26th Jun 20073:00 pmRNSDirector's Responsibilities
30th May 20075:13 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.